Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. The company employs 27 full-time employees The company went IPO on 2025-01-15. The firm mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.
HKPD stock price ended at $0.35 on 月曜日, after dropping 12.50%
On the latest trading day Jun 22, 2026, the stock price of HKPD fell by 12.50%, dropping from $0.37 to $0.35. During the session, the stock saw a volatility of 15.15%, with prices oscillating between a daily low of $0.33 and a high of $0.38. On the latest trading day, the trading volume for HKPD rose by 142.0K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 177.0K shares were traded, with a market value of approximately $8.2M.